Pubblicazioni scientifiche

Gelsomino F.; Facchinetti F.; Sisi M.; Zielli T.; Tiseo M.; Ardizzoni A., PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: The role of salvage chemo-immunotherapy combination, «IMMUNOTHERAPY», 2021, 13, pp. 363 - 369 [Articolo in rivista]

Rizzo A.; Mollica V.; Santoni M.; Ricci A.D.; Rosellini M.; Marchetti A.; Montironi R.; Ardizzoni A.; Massari F., Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials, «EUROPEAN UROLOGY FOCUS», 2021, 1077, pp. 1 - 8 [Articolo in rivista]

Ardizzoni A.; Azevedo S.; Rubio-Viqueira B.; Rodriguez-Abreu D.; Alatorre-Alexander J.; Smit H.J.M.; Yu J.; Syrigos K.; Trunzer K.; Patel H.; Tolson J.; Cardona A.; Perez-Moreno P.D.; Newsom-Davis T., Primary results from TAIL: A global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2021, 9, pp. 1 - 10 [Articolo in rivista] Open Access

Giovannini C.; Fornari F.; Piscaglia F.; Gramantieri L., Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas, «CELLS», 2021, 10, pp. 1 - 20 [Articolo in rivista] Open Access

Morgensztern D.; Dols M.C.; Ponce Aix S.; Postmus P.E.; Bennouna J.; Fischer J.R.; Juan-Vidal O.; Stewart D.J.; Ardizzoni A.; Bhore R.; Wolfsteiner M.; Reck M.; Talbot D.; Govindan R.; Ong T.J., nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+), «FRONTIERS IN ONCOLOGY», 2021, 10, pp. 1 - 9 [Articolo in rivista] Open Access

Pellegrino B.; Cavanna L.; Boggiani D.; Zamagni C.; Frassoldati A.; Schirone A.; Caldara A.; Rocca A.; Gori S.; Piacentini F.; Berardi R.; Brandes A.A.; Foglietta J.; Villa F.; Todeschini R.; Tognetto M.; Naldi N.; Bortesi B.; Montemurro F.; Ardizzoni A.; Boni L.; Musolino A., Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), «ESMO OPEN», 2021, 6, pp. 1 - 8 [Articolo in rivista] Open Access

Gramantieri, L; Giovannini, C; Piscaglia, F; Fornari, F, MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma, «JOURNAL OF HEPATOCELLULAR CARCINOMA», 2021, 8, pp. 369 - 385 [Articolo in rivista] Open Access

I. Capelli, M. Zoli, M. Righini, L. Faccioli, V. Aiello, L. Spinardi, D. Gori, F. Friso, A. Rustici, C. Bortolotti, C. Graziano, V. Mantovani, N. Sciascia, D. Mazzatenta, M. Seri, M. Pastore Trossello & G. La Manna, MR Brain Screening in ADPKD Patients, «CLINICAL NEURORADIOLOGY», 2021, 1, pp. 1 - 10 [Articolo in rivista] Open Access

Alessandrini A.; Brattoli G.; Piraccini B.M.; Di Altobrando A.; Starace M., The Role of Trichoscopy in Keratosis Follicularis Spinulosa Decalvans: Case Report and Review of the Literature, «SKIN APPENDAGE DISORDERS», 2021, 7, pp. 29 - 35 [Articolo in rivista]

Starace, M.; Mandel, V. D.; Francesca, B.; Alessandrini, A.; Misciali, C.; Apalla, Z.; Iorizzo, M.; Pellacani, G.; Silyuk, T.; Patrizi, A.; Piraccini, B. M., Lichen simplex chronicus of the scalp: dermoscopy and reflectance confocal microscopy features, «JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY», 2021, 35, pp. e450 - e452 [Articolo in rivista]

Starace M.; Carpanese M.A.; Alessandrini A.; Piraccini B.M.; Patrizi A.; Neri I., Tinea corporis incognito due to Microsporum Gypseum: Report of eight cases in children, «PEDIATRIC DERMATOLOGY», 2021, 38, pp. 652 - 654 [Articolo in rivista]

Alessandrini A.; Dika E.; Starace M.; Chessa M.A.; Piraccini B.M., Diagnosis of Melanonychia, «DERMATOLOGIC CLINICS», 2021, 39, pp. 255 - 267 [Articolo in rivista]

Fetta A.; Di Pisa V.; Ruscelli M.; Soliani L.; Sperti G.; Ubertiello S.; Ricci E.; Mainieri G.; Rocca A.; Mancardi M.M.; Giordano L.; Pruna D.; Vignoli A.; Provini F.; Cordelli D.M., Sleep in Children With Pallister Killian Syndrome: A Prospective Clinical and Videopolysomnographic Study, «FRONTIERS IN NEUROLOGY», 2021, 12, pp. 1 - 8 [Articolo in rivista] Open Access

Biagi C.; Cavallo A.; Rocca A.; Pierantoni L.; Antonazzo D.; Dondi A.; Gabrielli L.; Lazzarotto T.; Lanari M., Pulmonary and extrapulmonary manifestations in hospitalized children with mycoplasma pneumoniae infection, «MICROORGANISMS», 2021, 9, pp. 1 - 14 [Articolo in rivista] Open Access

Biserni G.B.; Scarpini S.; Dondi A.; Biagi C.; Pierantoni L.; Masetti R.; Sureshkumar S.; Rocca A.; Lanari M., Potential diagnostic and prognostic biomarkers for adenovirus respiratory infection in children and young adults, «VIRUSES», 2021, 13, pp. 1 - 18 [Articolo in rivista] Open Access

Rocca A.; Zarbo C.; Fabi M.; Mancini M.; Neri I.; Misciali C.; Patrizi A.; Lanari M., Case reports of annular erythema: A diagnostic clue of multisystem inflammatory syndrome in children related to coronavirus disease 2019?, «JOURNAL OF DERMATOLOGY», 2021, 48, pp. e454 - e455 [Articolo in rivista]

Dondi A.; Fetta A.; Lenzi J.; Morigi F.; Candela E.; Rocca A.; Cordelli D.M.; Lanari M., Sleep disorders reveal distress among children and adolescents during the Covid-19 first wave: results of a large web-based Italian survey, «THE ITALIAN JOURNAL OF PEDIATRICS», 2021, 47, pp. 1 - 10 [Articolo in rivista] Open Access

Rocca A.; Biagi C.; Scarpini S.; Dondi A.; Vandini S.; Pierantoni L.; Lanari M., Passive immunoprophylaxis against respiratory syncytial virus in children: Where are we now?, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, pp. 1 - 22 [Articolo in rivista] Open Access

Starace, M.; Alessandrini, A.; Piraccini, B. M., Dermoscopy of the Nail Unit, «DERMATOLOGIC CLINICS», 2021, 39, pp. 293 - 304 [Articolo in rivista]

Bruni F.; Di Altobrando A.; Alessandrini A.; Starace M.; Piraccini B.M.; Vincenzi C., Delayed access and provision of dermatological care as a collateral damage of COVID-19-related fear: Allergic contact dermatitis to fluconazole, «CONTACT DERMATITIS», 2021, 84, pp. 354 - 356 [Articolo in rivista]